HYPERTENSIVE DIABETIC RATS IN PHARMACOLOGICAL STUDIES

Citation
Pa. Vanzwieten et al., HYPERTENSIVE DIABETIC RATS IN PHARMACOLOGICAL STUDIES, Pharmacological research, 33(2), 1996, pp. 95-105
Citations number
44
Categorie Soggetti
Pharmacology & Pharmacy
Journal title
ISSN journal
10436618
Volume
33
Issue
2
Year of publication
1996
Pages
95 - 105
Database
ISI
SICI code
1043-6618(1996)33:2<95:HDRIPS>2.0.ZU;2-P
Abstract
Since hypertensive disease and diabetes frequently occur simultaneousl y there exists a requirement for animal models where both pathological entities are combined. The streptozotocin (STZ)-spontaneously hyperte nsive rat (STZ-SHR) and the obese Zucker rat are examples of animal mo dels where hypertension and diabetes occur simultaneously. STZ-SHRs de velop a hyperglycaemic syndrome, associated with other biochemical and morphological changes that to some extent approach insulin-dependent diabetes mellitus (type 1 diabetes) combined with hypertension. The ob ese (Fa/?) Zucker rat is characterized by the simultaneous occurrence of obesity, hyperglycaemia, hyperinsulinaemia, hyperlipidaemia and mod erate hypertension. As such it approaches the patient with non-insulin -dependent diabetes mellitus (type 2 diabetes) who is simultaneously h ypertensive. Lean (fa/fa) Zucker rats are suitable controls with respe ct to the obese animals. Both animal models (STZ-SHRs and obese Zucker rats) were characterized with respect to their biochemical, morphomet ric and haemodynamic properties. Both models were examined in particul ar with respect to the pharmacological characteristics of their cardio vascular system, as discussed in the present survey. (C) 1996 The Ital ian Pharmacological Society